Edge Capital Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $9.42M | Sell |
143,842
-168
| -0.1% | -$11K | 0.42% | 53 |
|
|
2024
Q3 | $11.2M | Sell |
144,010
-291
| -0.2% | -$22.7K | 0.5% | 43 |
|
|
2024
Q2 | $11.3M | Buy |
144,301
+3,665
| +3% | +$286K | 0.54% | 40 |
|
|
2024
Q1 | $9.53M | Buy |
140,636
+1,369
| +1% | +$92.7K | 0.47% | 50 |
|
|
2023
Q4 | $9.38M | Sell |
139,267
-998
| -0.7% | -$67.2K | 0.52% | 45 |
|
|
2023
Q3 | $9.5M | Sell |
140,265
-4,425
| -3% | -$300K | 0.62% | 36 |
|
|
2023
Q2 | $10.4M | Sell |
144,690
-5,719
| -4% | -$409K | 0.59% | 40 |
|
|
2023
Q1 | $10.4M | Sell |
150,409
-11,752
| -7% | -$816K | 0.64% | 39 |
|
|
2022
Q4 | $11M | Sell |
162,161
-2,921
| -2% | -$198K | 0.77% | 32 |
|
|
2022
Q3 | $9.05M | Buy |
165,082
+1,433
| +0.9% | +$78.6K | 0.74% | 32 |
|
|
2022
Q2 | $10.8M | Sell |
163,649
-2,606
| -2% | -$172K | 0.93% | 24 |
|
|
2022
Q1 | $11M | Sell |
166,255
-3,196
| -2% | -$212K | 0.76% | 31 |
|
|
2021
Q4 | $9.87M | Sell |
169,451
-1,941
| -1% | -$113K | 0.7% | 30 |
|
|
2021
Q3 | $10.3M | Sell |
171,392
-5,744
| -3% | -$345K | 0.82% | 26 |
|
|
2021
Q2 | $10.6M | Buy |
177,136
+60,576
| +52% | +$3.63M | 0.85% | 25 |
|
|
2021
Q1 | $5.8M | Buy |
+116,560
| New | +$5.8M | 0.49% | 51 |
|